Fundraising Fox
Khartis Therapeutics
5 known investors
Find your way into Khartis Therapeutics
Sign up to see every warm intro you have to Khartis Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Khartis Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Khartis is a drug discovery company developing oral therapies for patients with immune-mediated and chronic diseases. It operates in the biopharmaceutical and therapeutics sector.
Investors · 5
How we know: Foresite Capital's portfolio page · a partner's Signal profile · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Nextech Invest's portfolio page · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · open dataset · 5k.vc investor directory · Not right? Tell us
Funding
SEC filings, press & company announcements$95M disclosed across 1 of 2 rounds · 2026
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Khartis Therapeutics do?
- Khartis is a drug discovery company developing oral therapies for patients with immune-mediated and chronic diseases. It operates in the biopharmaceutical and therapeutics sector.
- Who are Khartis Therapeutics's investors?
- Khartis Therapeutics's investors include Foresite Capital, Nextech Invest, Alexandria, Lilly Asia Ventures, Longwood Fund.
- How much funding has Khartis Therapeutics raised?
- Khartis Therapeutics has disclosed $95M raised across 1 of its 2 known rounds.